Procurement Summary
Country : Bulgaria
Summary : Contract notice: Pharmaceutical products
Deadline : 07 May 2020
Other Information
Notice Type : Tender
TOT Ref.No.: 42106400
Document Ref. No. : 163680-2020
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : „МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ „ИВАН СКЕНДЕРОВ“ ЕООД
Office Name: „Многопрофилна болница за активно лечение „Иван Скендеров“ ЕООД
Address: ул. „Стара планина“ № 54
Town: Gotse Delchev
Postal Code: 2900
Contact Point: д-р Владислав Николаев Улевинов, дм — управител
Phone: +359 75195114
Fax: +359 0889878701
Bulgaria
Email :mbalgd@gmail.com
URL :www.mbal-gocedelchev.com
Tender Details
Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33600000
CPV Description: Pharmaceutical products.
Delivery of medicinal products for the needs of MBAL "Ivan Skenderov" Ltd., Gotse Delchev
The subject of the contract is delivery of medicinal products for the needs of "MBAL" Ivan Skenderov "Ltd.
Main Site: Hospital pharmacy" Hospital "Ivan Skenderov" EOOD with administrative address city of Gotse Delchev, 2900, Stara planina str. № 54
№ by order - ATC code - generic or other non-patent namenovelty - amount of active substance - dosage form - estimated amount for 1 year
A02 Medicines for treatment of acid disorders
1. A02BA03 Famotidine powd. inj. 20 mg solv.5 ml x 1 fl. 1330
2. A02BC01 Omeprazole powd. inf. 40 mg x 1 amp. 60
A03 Drugs for Functional Gastrointestinal Disorders
3. A03AD01 Papaverine sol. inj. 20 mg / ml 1 ml x 1 amp. 930
4. A03AD02 Drotaverine sol. inj. 20 mg/ ml 2 ml x 1 amp. 4020
5. A03BA01 Atropine sol. inj. 1 mg/ ml 1 ml x 1 amp. 790
6. A03BB01 Butylscopolamine sol. inj. 20 mg/ ml 1 ml x 1 amp. 2860
7. A03FA01 Metoclopramide sol. inj. 5 mg/ ml 2 ml x 1 amp. 1570
A05 Лекарства за лечение на жлъчка и черен дроб
8. А05ВА L-Ornithine/L-Aspartate conc. inf. 5 g/10 ml amp. 80
9. A05BA03 Silymarin caps. 90 mg x30 caps. 450
A10 Drugs for diabetes
10. A10AB01 Insulin human (fast acting) sol. inj. 100 IU / ml 3 ml x 1 sol. inj. 60
A11 Vitamins
11. A11CC04 Calcitriol caps. soft 0.25 mcg x 100 caps. 4860
12. A11GA01 Ascorbic acid sol. inj. 100 mg / ml 5 ml x 1 amp. 1600
A12 Mineral Supplements
13. A12AA03 Calcium gluconate sol. inj. 8.94 mg / ml 10 ml x 1 amp. 850
14. A12CC02 Magnesiumsulfate salt. inj. 403.8 mg / 10 ml x 1 amp. 1500
A16 Other Digestive and Metabolic Products
15. A16AA02 Ademetionine powd. inj. 500 mg solv. X 1 fl. 100
16. A16AX01 Thioctic acid conc. sol. inf. 600 mg 50 ml x 1 fl. 180
1.1. Pursuant to Art. 195, para. 1 of the Medicinal Products Act in the wholesale of medicinal products may carry outnatural and legal persons authorized to do so by a regulatory authority of the Member State concerned. For the persons under Art. 195, para. 1 of the Law on Medicinal Products in Human Medicine shall hold a valid certificate under Art. 203 of the Law on Medicinal Products in Human Medicine for wholesale registration in the Republic of BULGARIA, issuedbut by the Executive Director of the BDA.
For the persons under Art. 195, para. 2 of the Law on Medicinal Products in Human Medicine, which have warehouses on the territory of the Republic of BULGARIA, may carry out wholesale trade in medicinal products after obtaining a permit under Art. 202 of the Law on Medicinal Products in Human Medicine by the BDA Executive Director, issued bythe Executive Director of the BDA.
On the grounds of Art. 196, para. 1 of the Law on Medicinal Products in Human Medicine, a manufacturer of medicinal products within the meaning of the Law on Medicinal Products in Human Medicine may only wholesale medicinal products for which a manufacturing authorization has been issued under Art. 155 of the Law on Medicinal Products in Human Medicine, edby the Executive Director of the BDA.
On the grounds of Art. 196, para. 2 of the Law on Medicinal Products in Human Medicine, an importer of medicinal products within the meaning of the Law on Medicinal Products in Human Medicine may trade in wholesale only the medicinal products for which an import permit has been issued under Art. 164 of the Law on Medicinal Products in Human Medicine, issued by the BDA Executive Director.
1.2. A participant who offers medicinal products containing narcotic substances in accordance with the Law on Control of Narcotic Substances and Precursors, must hold a valid license for activities with narcotic substances under Art. 32, para. 1 of the Drug and Precursor Control Act, issued by the Minister of Health or byby the Deputy Minister.
The assignor does not set requirements for the economic and financial status of the participants in the procedure.
Internet address (URL): www.mbal-gocedelchev.com
Documents
Tender Notice